47506 Federal Register / Vol. 71, No. 159 / Thursday, August 17, 2006 / Notices 

information (i.e., address, phone 

number, fax number, e-mail address) for 

the corresponding or senior author 

should be provided at the end of the 

abstract. 

A statement indicating whether 

animals or humans were used in studies 

described in the poster must accompany 

all abstracts. All abstracts that involve 

studies using animals or animal tissues 

should be accompanied by a statement 

from the senior author certifying that all 

animal use was carried out in 

accordance with applicable laws, 

regulations, and guidelines, and that the 

appropriate Institutional Animal Care 

and Use Committee approved the 

studies. All abstracts that involve 

studies using humans should be 

accompanied by a statement from the 

senior author certifying that all human 

use was conducted in accordance with 

applicable laws, regulations, and 

guidelines, and that the appropriate 

Institutional Review Board approved the 

studies. 

Abstracts should be submitted by email to niceatm@niehs.nih.gov. The 

deadline for abstract submission is close 

of business on September 29, 2006. 

ICCVAM and NICEATM will review the 

submitted abstracts. The corresponding 

author will be notified of the abstract’s 

acceptance, along with guidelines for 

the poster format, approximately five 

weeks prior to the workshop. 

Request for Data 

NICEATM invites the submission of 

data and information from in vivo 

botulinum toxin testing and ex vivo and 

in vitro test methods being used or 

evaluated as potential alternatives to the 

mouse assay for botulinum toxin testing. 

The deadline for data submission is 

October 20, 2006. These data will be 

provided to the workshop participants 

and workshop panels for their review 

and consideration during workshop 

discussions. A similar request for data 

was announced previously (Federal 

Register, Vol. 71, No. 18, pp. 4603–

4604, January 27, 2006, available at 

http://iccvam.niehs.nih.gov/). 

When submitting chemical and 

protocol information/test data, please 

reference this Federal Register notice 

and provide appropriate contact 

information (name, affiliation, mailing 

address, phone, fax, e-mail, and 

sponsoring organization, as applicable). 

NICEATM prefers data to be submitted 

as copies of pages from study notebooks 

and/or study reports, if available. Raw 

data and analyses available in electronic 

format may also be submitted. Each 

submission should preferably include 

the following information, as 

appropriate: 

• Specific type of botulinum 

neurotoxin tested (e.g., Clostridium 

botulinum neurotoxin type A). 

• In vivo potency test protocol used 

and test results. 

• Individual animal responses, 

including time of onset of specific 

clinical signs and death. 

• Alternative ex vivo or in vitro test 

protocol used and test results. 

• The extent to which the study 

complied with national or international 

Good Laboratory Practice guidelines. 

• Date of the study. 

• The organization that conducted the 

study 

Background Information on ICCVAM, 

NICEATM, and SACATM 

ICCVAM is an interagency committee 

composed of representatives from 15 

U.S. Federal regulatory and research 

agencies that use or generate 

toxicological information. ICCVAM 

conducts technical evaluations of new, 

revised, and alternative methods with 

regulatory applicability and promotes 

the scientific validation and regulatory 

acceptance of toxicological test methods 

that more accurately assess the safety 

and hazards of chemicals and products 

and that refine, reduce, or replace 

animal use. The ICCVAM Authorization 

Act of 2000 (42 U.S.C. 2851–2, 2851–5 

[2000]) established ICCVAM as a 

permanent interagency committee of the 

NIEHS under NICEATM. NICEATM 

administers ICCVAM and provides 

scientific and operational support for 

ICCVAM–related activities. NICEATM 

and ICCVAM work collaboratively to 

evaluate new and improved test 

methods applicable to the needs of U.S. 

Federal agencies. Additional 

information about ICCVAM and 

NICEATM can be found at the 

ICCVAM–NICEATM Web site (http:// 

iccvam.niehs.nih.gov). 

SACATM provides external advice to 

the Director of the NIEHS, ICCVAM, and 

NICEATM regarding statutorily 

mandated duties of ICCVAM and 

activities of NICEATM. Additional 

information about SACATM, including 

the charter, roster, and records of past 

meetings can be found at http:// 

ntp.niehs.nih.gov/go/167. 

Dated: August 7, 2006. 

David A. Schwartz, 

Director, National Institute of Environmental 

Health Sciences and National Toxicology 

Program. 

[FR Doc. E6–13525 Filed 8–16–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; A CaseControl Study of ACL Risk Factors. 

Date: August 16, 2006. 

Time: 11:30 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jo Pelham, BA, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4102, MSC 7814, 

Bethesda, MD 20892, (301) 435–1786, 

pelhamj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Prognosis 

and Predictions of ACL Reconstruction. 

Date: August 21, 2006. 

Time: 11:30 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jo Pelham, BA, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4102, MSC 7814, 

Bethesda, MD 20892, (301) 435–1786, 

pelhamj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Influenza 

Vaccine Development. 

Date: August 22, 2006. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 


rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 71, No. 159 / Thursday, August 17, 2006 / Notices 47507 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jin Huang, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4095G, MSC 7812, 

Bethesda, MD 20892, 301–435–1187, 

jh377p@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Biomedical 

Engineering Research. 

Date: August 31, 2006. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Syed M. Quadri, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6210, 

MSC 7804, Bethesda, MD 20892, 301–435–

1211, quadris@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 9, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–6961 Filed 8–16–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Toxicology Program (NTP); 

Report on Carcinogens; Proposed 

Review Process for the 12th Report on 

Carcinogens (RoC): Request for Public 

Comment 

AGENCY: National Institute of 

Environmental Sciences (NIEHS), 

National Institutes of Health (NIH). 

ACTION: Request for public comment. 

SUMMARY: The NTP invites public 

comments on the proposed review 

process for the 12th RoC. The proposed 

review process for the 12th RoC is 

available on the NTP Web site http:// 

ntp.niehs.nih.gov (select ‘‘Report on 

Carcinogens’’) or by contacting Dr. C.W. 

Jameson at the address provided below. 

DATES: Comments will be accepted until 

September 18, 2006. 

ADDRESSES: All correspondence should 

be directed to Dr. C. W. Jameson, 

National Toxicology Program, Report on 

Carcinogens, 79 Alexander Drive, 

Building 4401, Room 3118, P.O. Box 

12233, Research Triangle Park, NC 

27709; telephone: (919) 541–4096, fax: 

(919) 541–0144, e-mail: 

jameson@niehs.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

This notice announces the proposed 

review process applicable to 

nominations to the 12th RoC. Two 

important new elements in the proposed 

RoC review process are (1) the public 

peer review of draft background 

documents by ad hoc scientific expert 

panels and (2) the peer review of draft 

substance profiles by the NTP Board of 

Scientific Counselors. In addition, the 

NTP will also, on a trial basis, prepare 

a response to public comments for the 

12th RoC. The proposed RoC review 

process is described in more detail on 

the NTP Web site (http:// 

ntp.niehs.nih.gov select ‘‘Report on 

Carcinogens’’). 

Request for Comments on the Proposed 

RoC Review Process 

The NTP invites public comments on 

the proposed 12th RoC review process. 

The NTP will consider any comments 

received on or before September 18, 

2006, as it finalizes the process to 

review nominations to the 12th RoC. 

The final 12th RoC review process will 

be announced in a future Federal 

Register notice and through NTP 

publications. Individuals submitting 

public comments are asked to include 

relevant contact information [name, 

affiliation and sponsoring organization 

(if any), address, telephone, fax, and email]. Written submissions will be made 

available on the NTP Web site as they 

are received (http://ntp.niehs.nih.gov/ 

select ‘‘Report on Carcinogens’’) and 

added to the public record. 

Background Information on the Report 

on Carcinogens 

The RoC is a congressionally 

mandated document (section 301(b)(4) 

of the Public Health Services Act, 42 

U.S.C. 241(b)(4)), published by the 

Secretary of Health and Human Services 

(HHS), that identifies agents, 

substances, mixtures, or exposure 

circumstances (collectively referred to 

as ‘‘substances’’) that may pose a 

carcinogenic hazard to human health. 

The Secretary, HHS, has delegated 

responsibility for preparing the draft 

report to the NTP. Substances are listed 

in the RoC as either known to be a 

human carcinogen or reasonably 

anticipated to be a human carcinogen. 

Development of the RoC is based upon 

a review of nominations (for new 

substances that are under consideration 

for listing or for reclassification of the 

listing status for a substance already 

listed) and a multi-step, scientific 

review process with opportunity for 

public comment. 

Dated: August 7, 2006. 

David A. Schwartz, 

Director, National Institute of Environmental 

Health Sciences and National Toxicology 

Program. 

[FR Doc. E6–13524 Filed 8–16–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[DHS–2006–0042] 

Science and Technology Directorate; 

Submission for Review; Reinstatement 

of a Previously Approved Information 

Collection Request for Support of 

SAFETY Act Application Kit 1640–0001 

AGENCY: Science and Technology 

Directorate, DHS. 

ACTION: 60 day Notice and request for 

comment. 

SUMMARY: The Department of Homeland 

Security (DHS) is soliciting public 

comment on the application forms and 

instructions (hereinafter ‘‘Application 

Kit’’) designed to assist persons 

applying for coverage under the 

SAFETY Act of 2002. This notice and 

request for comments is required by the 

Paperwork Reduction Act of 1995 (Pub. 

L. 104–13, 44 U.S.C. chapter 35). 

DATES: Comments are encouraged and 

will be accepted until October 16, 2006. 

ADDRESSES: You may submit comments, 

identified by docket number DHS–

2006–0042, by one of the following 

methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• E-mail: linda.vasta@dhs.gov. 

Include docket number DHS–2006–0042 

in the subject line of the message. 

• Mail: Science and Technology 

Directorate, ATTN: SAFETY Act, 245 

Murray Drive, Bldg 410, Washington, 

DC 20528. 

FOR FURTHER INFORMATION CONTACT: 

Linda Vasta (703) 575–4511 (this is not 

a toll free number). 

SUPPLEMENTARY INFORMATION: On June 8, 

2006, DHS published a final rule 

interpreting and implementing the 

SAFETY Act of 2002 (see 71 FR 33147). 

In connection with the issuance of this 

final rule, DHS consolidated the forms 

and instructions designed to assist 

persons applying for SAFETY Act 

coverage. The forms and instructions 

were consolidated into one Application 

Kit. 


rwilkins on PROD1PC63 with NOTICES